UK markets open in 1 hour 46 minutes
NIKKEI 225
38,109.37 -119.74 (-0.31%) HANG SENG
19,052.14 +88.46 (+0.47%) CRUDE OIL
78.08 -0.18 (-0.23%) GOLD FUTURES
2,360.30 -14.70 (-0.62%) DOW
39,512.84 +837.14 (+2.16%) Bitcoin GBP
48,650.86 -46.47 (-0.10%)
Oncopeptides AB (publ) (0RN4.IL)
IOB - IOB Delayed price. Currency in SEK
Add to watchlist
At close: 04:35PM BST
Currency in SEK
Valuation measures4
| Market cap (intra-day) | 423.87M |
| Enterprise value | 376.59M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 12.07 |
| Price/book (mrq) | 7.49 |
| Enterprise value/revenue | -48.38 |
| Enterprise value/EBITDA | -1.05 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.66 |
| 52-week change 3 | -58.44% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 10.5400 |
| 52-week low 3 | 0.0000 |
| 50-day moving average 3 | 4.2566 |
| 200-day moving average 3 | 6.7484 |
Share statistics
| Avg vol (3-month) 3 | 15.13k |
| Avg vol (10-day) 3 | 38.33k |
| Shares outstanding 5 | 90.44M |
| Implied shares outstanding 6 | 102.56M |
| Float 8 | 53.65M |
| % held by insiders 1 | 12.14% |
| % held by institutions 1 | 44.92% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Jun 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,216.52% |
Management effectiveness
| Return on assets (ttm) | -80.32% |
| Return on equity (ttm) | -260.68% |
Income statement
| Revenue (ttm) | 26.68M |
| Revenue per share (ttm) | 0.28 |
| Quarterly revenue growth (yoy) | 196.50% |
| Gross profit (ttm) | 8.35M |
| EBITDA | N/A |
| Net income avi to common (ttm) | -306.89M |
| Diluted EPS (ttm) | -3.3900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 293.77M |
| Total cash per share (mrq) | 3.12 |
| Total debt (mrq) | 121.18M |
| Total debt/equity (mrq) | 68.41% |
| Current ratio (mrq) | 5.86 |
| Book value per share (mrq) | 1.88 |
Cash flow statement
| Operating cash flow (ttm) | -314.75M |
| Levered free cash flow (ttm) | -205.2M |
© 2024 Yahoo. All rights reserved.